Drugs / peptide specific CTL
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03011255 | Dec 2016 → Aug 2017 | neoplasm of esophagus | Shixiu Wu | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | peptide specific CTL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03011255 ↗ |
| Route | Intravenous | “Peptide specific CTL will be administered by intravenous injection on day 28 of radiation.” NCT03011255 ↗ |